INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Six Flags Entertainment Corporation – FUN

NEW YORK CITY, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Six Flags Entertainment Corporation ("Six Flags" or the "Company") (NYSE:FUN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Six Flags and certain of […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bumble Inc. – BMBL

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bumble Inc. ("Bumble" or the "Company") (NASDAQ:BMBL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bumble and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Trade Desk, Inc. – TTD

NEW YORK CITY, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The Trade Desk, Inc. ("TTD" or the "Company") (NASDAQ:TTD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether TTD and certain of its officers

ALL WEATHER ARCHITECTURAL ALUMINUM EARNS “BEST PLACES TO WORK” 2025 AWARD

All Weather Selected to the North Bay Business Journal's Prestigious Annual List for the Sixth Consecutive Year For over 55 years, All Weather Architectural Aluminum (All Weather) has supported the commercial and high-end residential construction market on the West Coast with high quality, energy efficient, custom aluminum windows and doors. https://mma.prnewswire.com/media/1550292/All_Weather_Horz_Logo.jpg The North Bay Business

Anderson Longevity Clinic Franchise Expands to Sarasota, Florida

Anderson Longevity Clinic® Franchise is proud to announce the sale of a premier location in one of Sarasota's fastest-growing and most affluent areas. This landmark franchise unit will be operated by seasoned owner-operators with significant expertise in the longevity medicine field, bringing advanced, patient-centered healthcare to the community. The Sarasota clinic is slated to officially

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Roblox Corporation – RBLX

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Roblox Corporation ("Roblox" or the "Company") (NYSE:RBLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Roblox and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. – AXGN

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Axogen and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALT

NEW YORK CITY, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. – CAPR

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capricor and certain of its officers and/or directors

Scroll to Top